Foley & Lardner represented Processa Pharmaceuticals, while Sichenzia Ross Ference represented Spartan Capital Securities in the offering. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), a diversified clinical-stage company...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here